Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study

OBJECTIVES: To compare the safety and efficacy of lenvatinib (LEN) combined with camrelizumab plus transcatheter arterial chemoembolization (TACE-LEN-C) and TACE combined with LEN (TACE-LEN) in patients with unresectable hepatocellular carcinoma (uHCC). METHODS: Eighty-three patients with uHCC treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Bo, Zhang, Lijie, Sun, Tao, Ren, Yanqiao, Cao, Yanyan, Zhang, Weihua, Zhu, Licheng, Guo, Yusheng, Gui, Yuxi, Liu, Fengyong, Chen, Lei, Xiong, Fu, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511022/
https://www.ncbi.nlm.nih.gov/pubmed/36172158
http://dx.doi.org/10.3389/fonc.2022.982948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511022/
https://www.ncbi.nlm.nih.gov/pubmed/36172158
http://dx.doi.org/10.3389/fonc.2022.982948

Ejemplares similares